June 6, 2017 - By Clifton Ray
Ionis Pharmaceuticals Incorporated (NASDAQ:IONS) had an increase of 2.07% in short interest. IONS’s SI was 13.61 million shares in June as released by FINRA. Its up 2.07% from 13.33 million shares previously. With 2.05M avg volume, 7 days are for Ionis Pharmaceuticals Incorporated (NASDAQ:IONS)’s short sellers to cover IONS’s short positions. The SI to Ionis Pharmaceuticals Incorporated’s float is 11.09%. The stock decreased 1.68% or $0.83 during the last trading session, reaching $48.53. About shares traded. Ionis Pharmaceuticals Inc (NASDAQ:IONS) has risen 32.81% since June 6, 2016 and is uptrending. It has outperformed by 16.11% the S&P500.
Among 17 analysts covering WEX (NYSE:WEX), 6 have Buy rating, 1 Sell and 10 Hold. Therefore 35% are positive. WEX has $120 highest and $2 lowest target. $79.15’s average target is -25.62% below currents $106.42 stock price. WEX had 37 analyst reports since August 14, 2015 according to SRatingsIntel. The company was upgraded on Friday, January 22 by Wells Fargo. On Wednesday, February 3 the stock rating was maintained by Keefe Bruyette & Woods with “Outperform”. SunTrust initiated it with “Neutral” rating and $100 target in Friday, June 24 report. The firm has “Outperform” rating given on Tuesday, February 9 by Oppenheimer. The rating was downgraded by JP Morgan to “Underweight” on Friday, August 14. Deutsche Bank maintained the stock with “Hold” rating in Monday, September 21 report. The company was initiated on Friday, December 11 by Credit Suisse. The stock of WEX Inc (NYSE:WEX) earned “Market Perform” rating by Wells Fargo on Thursday, April 28. The firm has “Outperform” rating given on Friday, April 28 by Credit Suisse. The company was initiated on Friday, April 15 by Compass Point.
Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.19, from 1.16 in 2016Q3. It fall, as 26 investors sold WEX Inc shares while 77 reduced holdings. 30 funds opened positions while 70 raised stakes. 44.95 million shares or 11.27% more from 40.40 million shares in 2016Q3 were reported. Thompson Siegel And Walmsley Ltd holds 0% or 29 shares in its portfolio. State Of Wisconsin Invest Board reported 81,096 shares. Ledyard Bancorporation has invested 0% in WEX Inc (NYSE:WEX). Atlanta Capital Mgmt L L C has 1.65% invested in WEX Inc (NYSE:WEX) for 2.32 million shares. 2,480 are held by First Republic Inv Mgmt. Dimensional Fund Advsr Limited Partnership invested in 0.02% or 317,777 shares. Citigroup Inc invested in 5,791 shares. Arizona State Retirement invested 0.02% of its portfolio in WEX Inc (NYSE:WEX). Parametric Assoc Ltd Liability Corp has invested 0.01% of its portfolio in WEX Inc (NYSE:WEX). Eulav Asset holds 112,000 shares or 0.67% of its portfolio. Bessemer Gru owns 0% invested in WEX Inc (NYSE:WEX) for 274 shares. First Personal Fincl holds 0.03% of its portfolio in WEX Inc (NYSE:WEX) for 868 shares. Advantus Mngmt reported 4,786 shares or 0.01% of all its holdings. Tygh Management owns 48,880 shares. State Of Tennessee Treasury Department owns 40,000 shares.
The stock increased 4.93% or $5 during the last trading session, reaching $106.42. About shares traded. WEX Inc (NYSE:WEX) has risen 13.96% since June 6, 2016 and is uptrending. It has underperformed by 2.74% the S&P500.
WEX Inc. is a provider of corporate payment solutions. The company has market cap of $4.49 billion. The Firm operates through three divisions: Fleet Solutions, Travel and Corporate Solutions, and Health and Employee Benefit Solutions. It has a 66.69 P/E ratio. The Fleet Solutions segment provides clients with payment and transaction processing services designed for the needs of commercial and government fleets.
Analysts await WEX Inc (NYSE:WEX) to report earnings on July, 26. They expect $1.15 EPS, up 15.00% or $0.15 from last year’s $1 per share. WEX’s profit will be $48.52 million for 23.13 P/E if the $1.15 EPS becomes a reality. After $1.13 actual EPS reported by WEX Inc for the previous quarter, Wall Street now forecasts 1.77% EPS growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.